Simavita Receives ITAC Award for “Growing an IT Company Overseas”

Simavita Limited (TSX-V:SV)(ASX:SVA), a global leader in the digital healthcare sector, is delighted to announce that it received the “Growing an IT company Overseas” award at this week’s annual Information Technology in Aged Care (ITAC) conference. The ITAC conference is the Australian aged care industry’s pre-eminent annual event for technology solutions.

The award recognises Simavita’s program to drive penetration of its Smart Incontinence Management (SIM™) system into the global digital healthcare market.

Simavita CEO, Philippa Lewis commented, “Breaking into foreign regions with a digital healthcare platform is rare, so we are very excited that Simavita’s efforts are being recognised by our peers in the Australian digital healthcare space. We are starting to see the evidence of early stage traction from our work and this award acknowledges the momentum building offshore around SIM™ as we push hard to drive our Australian developed technology into other markets.”

For further information, see our website (www.simavita.com) or contact the persons outlined below.

About Simavita

Simavita is a digital healthcare company that has developed an innovative software platform. The first application for the platform is a world first solution for the management of urinary incontinence, with a focus on the elderly. This platform technology is an instrumented incontinence assessment application that provides evidence-based incontinence management care plans to the residential aged care market.

About SIM™

SIM™ is a wireless sensor technology that delivers evidence-based instrument incontinence data on individuals. SIM™ provides user friendly tools and software to assess the incontinence condition and to help plan better outcomes. SIM™ is used to detect, record and report incontinence events during a compulsory or recommended assessment period in residential aged care facilities to develop an evidence-based incontinence care plan.

Conducting assessments is mandatory in many countries and the incontinence assessment creates an influential element of care of each individual. For more information on Simavita or SIM™, please visit www.simavita.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151126005553/en/